Centocor Loses Bid To Dismiss Remicade Suit

Law360, New York (November 8, 2010, 6:29 PM EST) -- Johnson & Johnson Inc. subsidiary Centocor Ortho Biotech Inc. has failed to persuade a federal judge to throw out a suit a patient filed over a warning label developed for Remicade.

Judge James G. Carr of the U.S. District Court for the Northern District of Ohio ruled that Centocor had not, as a matter of law, warned patient Anthony DeGidio that he might contract a noninfectious lung disease if he used Remicade.

The warning did mention that Remicade might cause an infectious lung disease, but had...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.